Gastrinomas: Advances in diagnosis and management

Neuroendocrinology

Volumn 80, Issue SUPPL. 1, 2004, Pages 23-27

  Jensen, Robert T ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

Gastrinomas; Somatostatin receptor scintigraphy; Zollinger ellison syndrome

Indexed keywords

ALPHA INTERFERON; ANGIOPEPTIN; DOXORUBICIN; ESOMEPRAZOLE; FLUOROURACIL; HISTAMINE H2 RECEPTOR; HISTAMINE H2 RECEPTOR ANTAGONIST; LANSOPRAZOLE; OCTREOTIDE; OMEPRAZOLE; PANTOPRAZOLE; PENTETATE INDIUM IN 111; PROTON PUMP INHIBITOR; RABEPRAZOLE; SOMATOSTATIN DERIVATIVE; STOMACH SECRETION INHIBITOR; STREPTOZOCIN; YTTRIUM 90;

CANCER SURVIVAL; CLINICAL FEATURE; CONFERENCE PAPER; DIFFERENTIAL DIAGNOSIS; EPIDEMIOLOGICAL DATA; GASTRINOMA; GASTROESOPHAGEAL REFLUX; HUMAN; LIVER METASTASIS; PATHOGENESIS; PATHOPHYSIOLOGY; PATIENT CARE; PHARMACEUTICAL CARE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; RADIODIAGNOSIS; SCINTIGRAPHY; SIDE EFFECT; STOMACH ACID SECRETION; SURGICAL TECHNIQUE; SYMPTOM; TUMOR DIAGNOSIS; TUMOR LOCALIZATION; ZOLLINGER ELLISON SYNDROME;

FEMALE; GASTRINOMA; HUMANS; MALE; MODELS, BIOLOGICAL; NEOPLASM METASTASIS; PANCREATIC NEOPLASMS; SOMATOSTATIN; ZOLLINGER-ELLISON SYNDROME;

EID: 6044228321     PISSN: 00283835     EISSN: None     Source Type: Journal    
DOI: 10.1159/000080736     Document Type: Conference Paper

References (18)

1. Roy P, Venzon DJ, Shojamanesh H, Abou-Saif A, Peghini P, Doppman JL, Gibril F, Jensen RT: Zollinger-Ellison syndrome: Clinical presentation in 261 patients. Medicine (Baltimore) 2000;79:379-411.
2. Jensen RT: Zollinger-Ellison syndrome; in Doherty GM, Skogseid B (eds): Surgical Endocrinology: Clinical Syndromes. Philadelphia, Lippincott Williams & Wilkins, 2001, pp 291-344.
3. Corleto VD, Delle Fave G, Jensen RT: Molecular insights into gastrointestinal neuroendocrine tumors: Importance and recent advances. Dig Liver Dis 2000;34:668-680.
4. Weber HC, Venzon DJ, Lin JT, Fishbein VA, Orbuch M, Strader DB, Gibril F, Metz DC, Fraker DL, Norton JA, Jensen RT: Determinants of metastatic rate and survival in patients with Zollinger-Ellison syndrome: A prospective long-term study. Gastroenterology 1995;108:1637-1649.
5. Yu F, Venzon DJ, Serrano J, Goebel SU, Doppman JL, Gibril F, Jensen RT: Prospective study of the clinical course, prognostic factors and survival in patients with longstanding Zollinger-Ellison syndrome. J Clin Oncol 1999;17:615-630.
6. Corleto VD, Annibale B, Gibril F, Angeletti S, Serrano J, Venzon DJ, Delle Fave G, Jensen RT: Does the widespread use of proton pump inhibitors mask, complicate and/or delay the diagnosis of Zollinger-Ellison syndrome. Aliment Pharmacol Ther 2001;15:1555-1561.
7. Roy P, Venzon DJ, Feigenbaum KM, Koviack PD, Bashir S, Ojeaburu JV, Gibril F, Jensen RT: Gastric secretion in Zollinger-Ellison syndrome: Correlation with clinical expression, tumor extent and role in diagnosis - A prospective NIH study of 235 patients and review of the literature in 984 cases. Medicine (Baltimore) 2001;80:189-222.
8. Frucht H, Howard JM, Slaff JI, Wank SA, McCarthy DM, Maton PN, Vinayek R, Gardner JD, Jensen RT: Secretin and calcium provocative tests in the Zollinger-Ellison syndrome: A prospective study. Ann Intern Med 1989;111:713-722.
9. Norton JA, Jensen RT: Current surgical management of Zollinger-Ellison syndrome (ZES) in patients without multiple endocrine neoplasia-type 1 (MEN1). Surg Oncol 2003;12:145-151.
10. Kwekkeboom D, Krenning EP, deJong M: Peptide receptor imaging and therapy. J Nucl Med 2000;41:1704-1713.
11. Gibril F, Reynolds JC, Doppman JL, Chen CC, Venzon DJ, Termanini B, Weber HC, Stewart CA, Jensen RT: Somatostatin receptor scintigraphy: Its sensitivity compared with that of other imaging methods in detecting primary and metastatic gastrinomas: A prospective study. Ann Intern Med 1996;125:26-34.
12. Metz DC, Pisegna JR, Fishbeyn VA, Benya RV, Feigenbaum KM, Koviack PD, Jensen RT: Currently used doses of omeprazole in Zollinger-Ellison syndrome are too high. Gastroenterology 1992;103:1498-1508.
13. Norton JA, Fraker DL, Alexander HR, Venzon DJ, Doppman JL, Serrano J, Goebel SU, Peghini P, Roy PK, Gibril F, Jensen RT: Surgery to cure the Zollinger-Ellison syndrome. N Engl J Med 1999;341:635-644.
14. Norton JA, Alexander HR, Fraker DL, Venzon DJ, Jensen RT: Does the use of routine duodenotomy (DUODX) affect rate of cure, development of liver metastases or survival in patients with Zollinger-Ellison syndrome (ZES)? Ann Surg 2004;239:617-626.
15. Jensen RT: Management of the Zollinger-Ellison syndrome in patients with multiple endocrine neoplasia type 1. J Intern Med 1998;243:477-488.
16. Sutliff VE, Doppman JL, Gibril F, Yu F, Serrano J, Venzon DJ, Jensen RT: Growth of newly diagnosed, untreated metastatic gastrinomas and predictors of growth patterns. J Clin Oncol 1997;15:2420-2431.
17. Arnold R, Wied M, Behr TH: Somatostatin analogues in the treatment of endocrine tumours of the gastrointestinal tract. Expert Opin Pharmacother 2002;3:643-656.
18. Shojamanesh H, Gibril F, Louie A, Ojeaburu JV, Bashir S, Abou-Saif A, Jensen RT: Prospective study of the anti-tumor efficacy of longterm octreotide treatment in patients with progressive metastatic gastrinomas. Cancer 2002;94:331-343.